Clinical Trials on Alkalosis in Colombia

Total 15 results

Abbott

Completed

Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis

Ankylosing Spondylitis

Canada
University of British Columbia
Canadian Institutes of Health Research (CIHR); University of Toronto; University... and other collaborators

Active, not recruiting

Employment and Arthritis: Making it Work (MIW)

Rheumatoid Arthritis | Lupus Erythematosus, Systemic | Spondylarthropathy | Psoriatic Arthritis | Ankylosing Spondylitis | Other Connective Tissue Diseases

Canada
Charite University, Berlin, Germany

Unknown

Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA)

Spondylarthropathy | Spondylitis, Ankylosing | Spondyloarthritis

China, Netherlands, United States, Belgium, Brazil, Canada, Colombia, Denmark, France, Germany, Hungary, Indonesia, Ireland, Italy, Mexico, Spain, Switzerland, Taiwan, Turkey, United Kingdom
AbbVie (prior sponsor, Abbott)
Cato Research; JSS Medical Research Inc.

Completed

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis (Complete-AS)

Ankylosing Spondylitis

Canada
Pfizer

Completed

Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes (EMBARK)

Spondylitis, Ankylosing

Belgium, Korea, Republic of, Spain, France, Taiwan, Germany, Argentina, Czech Republic, United Kingdom, Hungary, Russian Federation, Colombia, Finland, Netherlands
Centocor, Inc.
Schering-Plough

Completed

A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis

Spondylitis, Ankylosing

United States, Germany, Finland, Taiwan, Korea, Republic of, Canada, Belgium, Netherlands, France
Novartis Pharmaceuticals

Completed

Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

Ankylosing Spondylitis

India, Turkey, Belgium, Thailand, United States, Czechia, Greece, Russian Federation, Bulgaria, Guatemala, Italy, Korea, Republic of, Malaysia, Sweden, Colombia, Philippines, Poland, Brazil
Pfizer

Completed

Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA (RE-EMBARK)

Spondylitis, Ankylosing

United States, Sweden, Taiwan, Colombia, Hungary, Belgium, Australia, Finland, Netherlands, Spain, Czechia, Poland, France, Germany
Novartis Pharmaceuticals

Completed

16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis (MEASURE4)

Spondylitis, Ankylosing

Germany, Austria, Denmark, United States, Australia, Netherlands, Poland, Italy, Bulgaria, Spain, Russian Federation, United Kingdom, Greece, Czechia, Canada, Norway, Slovakia, Switzerland, Finland
Novartis Pharmaceuticals

Completed

Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis (ASLeap)

Ankylosing Spondylitis

United States
Eli Lilly and Company

Withdrawn

Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS) (SPIRIT A1)

Spondylitis, Ankylosing

Spain, United States, Hungary, Belgium, France, Mexico, Netherlands, Poland, Russian Federation, Ukraine, United Kingdom, Canada, Argentina, Germany, Czech Republic
Novartis Pharmaceuticals

Recruiting

A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission

Non-radiographic Axial Spondyloarthritis

Belgium, Netherlands, Italy, Thailand, Hungary, Malaysia, Germany, Israel, France, Czechia, Colombia, Romania, Poland, Turkey, Vietnam, Brazil, Mexico, Philippines
Novartis Pharmaceuticals

Completed

Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) (SURPASS)

Ankylosing Spondylitis

Taiwan, Netherlands, United Kingdom, Germany, Korea, Republic of, Israel, United States, Belgium, Greece, Philippines, Russian Federation, Spain, Turkey, Portugal, Mexico, Peru, Denmark, France, Czechia, Australia, Canada, Poland, J... and more
AstraZeneca

Completed

Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS). (RATIONAL)

Osteoarthritis (OA) | Rheumatoid Arthritis (RA) | Ankylosing Spondylitis (AS)

Mexico, Vietnam, Malaysia, Argentina, Philippines, Korea, Republic of, Venezuela, Colombia, Russian Federation, Thailand
Biogen

Completed

One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study (PERFUSE)

Arthritis, Rheumatoid | Crohn's Disease | Arthritis, Psoriatic | Colitis, Ulcerative | Spondylitis, Ankylosing

France

Clinical Trials on Alkalosis in Colombia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations